Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.
about
Viral hepatitis and hepatocellular carcinomaEvidence for hepatitis C viral infection in patients with primary hepatocellular carcinomaDetection of replicative hepatitis C virus sequences in hepatocellular carcinomaAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.Hepatocellular carcinoma and hepatitis C in the United States.Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.Hepatitis C virus RNA in southern African blacks with hepatocellular carcinomaLow prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China.Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan.The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment unitsCumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USAInfection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California.Etiological and molecular profile of hepatocellular cancer from India.Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma.Hepatitis C virus infection with progression to hepatocellular carcinoma: a report of five prospectively followed patients in Sweden.Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma.High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.Assessment of a hepatitis educational group for veterans with substance use disorders.Cancer risk after renal transplantation in Japan.High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.Hepatitis Viruses and Human Hepatocellular Carcinoma.Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010.Parenchymal echo patterns of cirrhotic liver analysed with a neural network for risk of hepatocellular carcinoma.Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.Chronic hepatitis C
P2860
Q21245597-A27F8D8B-6E5C-4707-B781-B251153398B2Q27469317-C2F06938-8361-452B-85C6-8BE291E2455DQ27478449-63C99F20-5581-4875-8F83-737D2132DB14Q30479629-41C91210-DEF6-4E9A-8BEA-131F75329839Q33277431-67AA15D7-62B1-4AD6-8BAB-5497D55E2585Q34528514-9D215770-7574-4FB2-ACDD-F1D941DC27FFQ35274812-A5218E1A-EE21-4FEF-9926-391C8D916AA7Q36135489-CA4E688A-CDA6-4BDA-8827-8DF5BC207D6EQ36135809-FC11C3EF-FB15-4880-8C6E-AAB12E7148C5Q36184703-CF084B42-53BF-4747-AB31-A0E92620521CQ36273036-63F0F654-869D-42ED-AA0F-43721483DB3FQ36732386-3DCF1ACF-3307-41E7-8BFC-3F4860059AC2Q37175484-676E0156-381A-46C6-8562-5D3200CAEBC1Q39820778-13CFE984-F90B-43CC-83DB-72A5E1F13619Q41691096-793CFD90-3C57-4F7B-92E9-4CF7D134B217Q42987200-887824DA-FC4E-49E0-B9F3-9EEC62691097Q42994894-A76882F8-2D0B-453F-9E43-66AB59A5537FQ43035221-D75E3CDB-5ED1-499C-A67E-47A1CB122E47Q43036129-AE67D1D1-CAD8-4ABC-9128-776223F268F4Q43039375-1ABFE06A-2FD5-4A1F-AB59-EB186C0D22E2Q43168953-279AF536-BFA5-4790-8DF7-61E9AA470822Q43816870-29067F22-957E-4F12-9BD5-FB82BAB7D63CQ43923526-020C9439-CD54-4839-A282-BA8438C6E78AQ45782111-F9ADA750-9B69-4069-A399-90DD21D2C223Q51845898-2EFBB455-D190-4FD2-89FB-E5B2EB02E06FQ52139868-18978842-7825-4CDC-9ABF-82CD9FB3FCAFQ52654020-58A9FF27-E7FF-4934-92CB-7B86D0B84F30Q53454226-14BE3B4B-ADF8-409E-ABA1-553B3211E533Q55005053-770A3C95-7508-4E7A-8EF1-2C1EEB13C875Q56929229-CC8B48C8-A106-4568-BC70-9A948CDBBB35
P2860
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Prevalence of hepatitis B and ...... arcinoma in the United States.
@en
Prevalence of hepatitis B and ...... arcinoma in the United States.
@nl
type
label
Prevalence of hepatitis B and ...... arcinoma in the United States.
@en
Prevalence of hepatitis B and ...... arcinoma in the United States.
@nl
prefLabel
Prevalence of hepatitis B and ...... arcinoma in the United States.
@en
Prevalence of hepatitis B and ...... arcinoma in the United States.
@nl
P2093
P356
P1476
Prevalence of hepatitis B and ...... arcinoma in the United States.
@en
P2093
P304
P356
10.1093/JNCI/82.12.1038
P407
P577
1990-06-01T00:00:00Z